Skip to main content
. 2015 Jun 30;15:203. doi: 10.1186/s12906-015-0745-x

Fig. 4.

Fig. 4

Immunohistochemical staining with MMP-9 in control and treated groups. The pattern of distribution of the MMP-9 staining is similar as with the VEGF study, but anti–MMP-9 antibody immunoreactivity was more intense in TC on day 8 (arrows); on the day 15, the immunoreactions were reduced and no differences were observed among the treated groups (arrowheads)